Molecular analysis of hormone receptor positive (luminal) breast cancers: what have we learnt?

@article{Loi2008MolecularAO,
  title={Molecular analysis of hormone receptor positive (luminal) breast cancers: what have we learnt?},
  author={Sherene Loi},
  journal={European journal of cancer},
  year={2008},
  volume={44 18},
  pages={2813-8}
}
Recently, whole-genome molecular profiling of cancers has revealed that breast cancer consists of a number of distinct diseases at the biological level, each of which will require independent research into the most suitable therapy for that patient. In particular, this has long confirmed the clinician's impression that the clinical behaviour of oestrogen receptor (ER)-positive breast cancer can be markedly heterogeneous despite similar levels of expression of the oestrogen receptor. At present… CONTINUE READING